Cell-mediated immunity to varicella-zoster virus measured by virus inactivation: mechanism and blocking of the reaction by specific antibody
- PMID: 225269
- PMCID: PMC414433
- DOI: 10.1128/iai.25.1.164-169.1979
Cell-mediated immunity to varicella-zoster virus measured by virus inactivation: mechanism and blocking of the reaction by specific antibody
Abstract
The process whereby varicella-zoster (V-Z) virus is inactivated in vitro by immune human peripheral blood leukocytes stimulated with V-Z antigen was examined. It was found that stimulation of leukocytes by V-Z antigen, but not by other viral antigens, was required for inactivation of V-Z virus to occur. Viral inactivation could be blocked by addition of V-Z antiserum to either the stimulation phase of the reaction or the inactivation phase, further demonstrating the specificity of the reaction. In addition these blocking experiments suggested that modulation of V-Z membrane antigen by antiserum occurred with an accompanying loss of immunological recognition of virus-infected cells. Inactivation of V-Z virus in vitro in this study appeared not to be dependent upon the secretion of interferon or upon antibody-dependent cellular cytotoxicity. The specific cells required for V-Z inactivation were T lymphocytes and monocytes (macrophage precursors).
Similar articles
-
Inactivation of varicella zoster virus in vitro: effect of leukocytes and specific antibody.Infect Immun. 1981 Aug;33(2):507-11. doi: 10.1128/iai.33.2.507-511.1981. Infect Immun. 1981. PMID: 6268546 Free PMC article.
-
Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections.Infect Immun. 1979 Jul;25(1):170-4. doi: 10.1128/iai.25.1.170-174.1979. Infect Immun. 1979. PMID: 225270 Free PMC article.
-
Cell-mediated immunity to varicella-zoster virus demonstrated by viral inactivation with human leukocytes.Infect Immun. 1976 Jun;13(6):1549-53. doi: 10.1128/iai.13.6.1549-1553.1976. Infect Immun. 1976. PMID: 184040 Free PMC article.
-
Cell-mediated immunity to varicella-zoster virus.J Infect Dis. 1992 Aug;166 Suppl 1:S35-41. doi: 10.1093/infdis/166.supplement_1.s35. J Infect Dis. 1992. PMID: 1320649 Review.
-
Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.Mol Biol Med. 1989 Oct;6(5):453-62. Mol Biol Med. 1989. PMID: 2560525 Review.
Cited by
-
Inactivation of varicella zoster virus in vitro: effect of leukocytes and specific antibody.Infect Immun. 1981 Aug;33(2):507-11. doi: 10.1128/iai.33.2.507-511.1981. Infect Immun. 1981. PMID: 6268546 Free PMC article.
-
Inhibition of varicella-zoster virus in vitro by human peripheral blood mononuclear cells.Clin Exp Immunol. 1989 Mar;75(3):381-6. Clin Exp Immunol. 1989. PMID: 2539281 Free PMC article.
-
Viral load, clinical disease severity and cellular immune responses in primary varicella zoster virus infection in Sri Lanka.PLoS One. 2008;3(11):e3789. doi: 10.1371/journal.pone.0003789. Epub 2008 Nov 21. PLoS One. 2008. PMID: 19023425 Free PMC article.
-
Cellular and humoral immune responses to varicella-zoster virus in immunocompromised patients during and after varicella-zoster infections.Infect Immun. 1979 Jul;25(1):170-4. doi: 10.1128/iai.25.1.170-174.1979. Infect Immun. 1979. PMID: 225270 Free PMC article.
-
Use of bone marrow fibroblasts to prepare targets for an HLA restricted-cytotoxicity assay system.J Clin Microbiol. 1984 Oct;20(4):696-700. doi: 10.1128/jcm.20.4.696-700.1984. J Clin Microbiol. 1984. PMID: 6490855 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources